Tapestry, Inc. Operating Cash Flow decreased by 75.7% to $262.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 82.0%, from $144.30M to $262.60M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -2.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $379.10M | $21.80M | $646.30M | -$51.70M | $236.80M | -$170.40M | $632.80M | $112.40M | $400.40M | $75.30M | $826.50M | $97.80M | $256.00M | $119.50M | $506.00M | $144.30M | $446.80M | $112.60M | $1.08B | $262.60M |
| QoQ Change | — | -94.2% | >999% | -108.0% | +558.0% | -172.0% | +471.4% | -82.2% | +256.2% | -81.2% | +997.6% | -88.2% | +161.8% | -53.3% | +323.4% | -71.5% | +209.6% | -74.8% | +860.1% | -75.7% |
| YoY Change | — | — | — | — | -37.5% | -881.7% | -2.1% | +317.4% | +69.1% | +144.2% | +30.6% | -13.0% | -36.1% | +58.7% | -38.8% | +47.5% | +74.5% | -5.8% | +113.7% | +82.0% |